P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Additional Paid In Capital
â‚©180.6B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Additional Paid In Capital
â‚©14.8T
CAGR 3-Years
159%
CAGR 5-Years
79%
CAGR 10-Years
44%
SK Bioscience Co Ltd
KRX:302440
Additional Paid In Capital
â‚©1.2T
CAGR 3-Years
86%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Additional Paid In Capital
â‚©382.7B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
2%
H
Hugel Inc
KOSDAQ:145020
Additional Paid In Capital
â‚©394.5B
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Additional Paid In Capital
â‚©121.7B
CAGR 3-Years
-11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
248 805.39 KRW
Undervaluation 20%
Intrinsic Value
Price
P

See Also

What is PharmaResearch Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
180.6B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Additional Paid In Capital amounts to 180.6B KRW.

What is PharmaResearch Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
8%

Over the last year, the Additional Paid In Capital growth was 6%. The average annual Additional Paid In Capital growth rates for PharmaResearch Co Ltd have been 9% over the past three years , 8% over the past five years .

Back to Top